1. Introduction {#sec1}
===============

Pericarpium Citri Reticulatae (Chenpi in Chinese) has been widely used as an herbal medicine for a long time in China, Korea, and Japan, for its pharmacologic activity, rich resources, low toxicity, and costs. Chenpi is the dried ripe fruit peel of *Citrus reticulata* Blanco and its cultivars, gathered from September to December \[[@B1]\]. Their main cultivars are *Citrus reticulata* "Chachi," Citrus Reticulata "Dahongpao," and *Citrus erythrosa* Tanaka. In Chinese people\'s traditional use, Chenpi is mostly utilized to eliminate phlegm and strengthen spleen \[[@B2]\]. Moreover, Chenpi is extensively added to food as a condiment.

It is well known that Chenpi contains various bioactive compounds, such as flavonoids, phenolic acids, and limonoids \[[@B2], [@B3]\]. In the present study, most reports on Chenpi focus on phenolic compounds and flavonoids \[[@B3]--[@B7]\], but few focus on volatile compounds which also have strong pharmacologic bioactivities. For example, high-performance liquid chromatography (HPLC), high-speed countercurrent chromatography (HSCCC), and capillary electrophoresis (CE) have been applied for the determination of phenolic compounds and flavonoids of Chenpi \[[@B8]--[@B10]\]. However, reviewing the literature, it seems that the chemical composition of the volatile oil of Chenpi has been little investigated \[[@B11]\]. Furthermore, the volatile compounds of Chenpi may contribute to pharmacological effects of Chenpi extracts reported above \[[@B12], [@B13]\]. Therefore, a method able to rapidly identify the volatile compounds of Chenpi could be a useful tool for the purpose of a complete phytochemical analysis.

Gas chromatography-mass spectroscopy (GC-MS) has been used for the qualitative analysis of the volatile constituents in Chenpi \[[@B11]\]. But it is difficult to achieve the complete separation of minor volatile components and many coelution volatile constituents. To solve these problems, it is necessary to use multidimensional gas chromatography. Comprehensive two-dimensional gas chromatography with high-resolution time-of-flight mass spectrometry (GC × GC-HR-TOFMS) is a new developed powerful and versatile analytical tool, which combines two powerful analytical technologies with complementary attributes \[[@B14], [@B15]\]. GC × GC separates chemical species with two capillary columns interfaced by a modulator that traps and concentrates eluents from the first column, and it then introduces them into the second column, producing a full secondary chromatogram for each single data point of a traditional one-dimensional separation \[[@B16], [@B17]\]. HR-TOFMS provides mass precision that is fine enough to distinguish elemental compositions, providing a more definitive basis for molecular identification. GC × GC is important for HR-TOFMS because the better separations significantly reduce the coelution and the problems of mass spectral mixing. And, HR-TOFMS is important for GC × GC because the structural and compositional information available with HR-TOFMS aids in the interpretation of the rich, complex data from GC × GC separations \[[@B18]\]. GC × GC-TOFMS has been successfully applied in the volatile oil study and greatly improves the result of component separation and identification \[[@B19], [@B20]\]. In this study, the volatile oil of Chenpi was firstly separated and detected with GC × GC-HR-TOFMS ([Figure 1](#fig1){ref-type="fig"}).

2. Materials and Methods {#sec2}
========================

2.1. Samples {#sec2.1}
------------

Chenpi sample (fruit peels of *Citrus reticulate* "Dahongpao") was collected from Zigong in Sichuan province, China. The sample was authenticated by Professor Chen Jianwei from Nanjing University of Traditional Chinese Medicine, China.

2.2. Extraction of Volatile Oil {#sec2.2}
-------------------------------

After the sample was dried for 2 h at 45°C and smashed, 50 g of sample was swollen with 600 mL of distilled water in a standard extractor for extracting volatile oil for 3 h. Then, the volatile oil was dried over anhydrous sodium sulphate until all the water was dried and then stored in the dark glass bottle at 4°C prior to GC × GC-HR-TOFMS analysis.

2.3. GC-MS System and GC × GC-HR-TOFMS Apparatus {#sec2.3}
------------------------------------------------

GC × GC separations were performed by Tofwerk AG (Thun, Switzerland) on an Agilent 7890 A GC and 7693 autosampler with: 1 *μ*L splitless injection; column one DB-XLB (Agilent), 15 m × 0.25 mm, 0.25 *μ*m film thickness; column two BPX-50 (SGE), 1 m × 0.1 mm, 0.1 *μ*m film thickness; oven temperature from 50 to 230°C at 2.0°C min^−1^ ramp; inlet pressure from 35 PSI to 61.5 PSI at 0.28 PSI min^−1^; injection temperature 250°C; transfer line temperature 300°C; Zoex ZX2 thermal modulator with a 7 s modulation period, 300 ms modulation duration, 375°C hot jet temperature, 18 L min^−1^ cold jet nitrogen flow rate, and 40 PSI hot jet nitrogen pressure. The Zoex FasTOF time-of-flight- (TOF-) HRMS system used 70 eV EI ion source, 280°C ion source temperature, a mass range of *m/z* 50--450 with 4000 FWHM resolution, and 100 spectra per second acquisition rate.

2.4. Data Conversion and Peak Table Generation {#sec2.4}
----------------------------------------------

The final data for each chromatogram is an array of 1000 × 600 data points, each data point with a HRMS vector of 40 K intensities. Thus, each chromatogram has 24 billion values requiring 96 gigabytes for representing for single-precision floating point numbers without compression. The set of 18 chromatograms has more than 1.7 terabytes of uncompressed data. The data were compressed and stored by the Zoex FasTOF system to HDF5-format files and were processed with GC Image GC × GC Software R2.1. In order to manage such large files on computers with limited random access memory (RAM), GC Image Software maintains a chromatogram with integer mass or centroid-resampled spectra in RAM and accesses the HR-MS data from disk as needed. GC Image can export raw data and computed results to nonproprietary file formats for processing with external software. The components can be quantified by Zoex software (Zoex Corp, Lincoln, NE, USA).

All peaks with signal-to-noise ratio higher than 100 were found in the raw GC × GC chromatogram. The workstation can automatically give the parameters such as similarity, reverse, and probability of peaks via comparing them with the compounds in the library. The results were combined in a peak table. The NIST/EPA/NIH Mass Spectral Library Version 2.0 was used in this work.

3. Results and Discussion {#sec3}
=========================

3.1. Qualitative Analysis of Chenpi Volatile Oil {#sec3.1}
------------------------------------------------

The column system is nearly orthogonal and provides a structured separation. A typical two-dimensional separation/total ion chromatogram (TIC) and three-dimensional chromatogram are shown in [Figure 2](#fig2){ref-type="fig"}. In the GC × GC system, compounds are separated by volatility difference on the first dimension nonpolar column and by polarity on the second medium-polar column. The GC × GC system accomplishes the true orthogonal separation on account for both the change of the polarity of two fixed phases and the linear temperature programming.

Using GC × GC-HR-TOFMS, the quantity of the detected components was up to 834. Compared to the traditional identification method such as GC-MS, the analysis from GC × GC-HR-TOFMS becomes more reliable, relying on the combined identification information including retention times, similarity, reverse match factor, and probability. The similarity and reverse match factors indicate how well a mass spectrum matches the library spectrum, but the isomers have similar mass spectra. In this case, the probability is used to determine whether the peaks with the same name belong to one compound or several compounds. The GC × GC-HR-TOF/MS software was used to find all the peaks in the raw GC × GC chromatogram. A library search was carried out for all the peaks using the NIST/EPA/NIH version 2.0, and the results were combined in a single peak table. A similarity and reverse match factor above 583 and 612, respectively, indicates that an acquired mass spectrum usually shows a good match with the library spectrum. Because of the numerous isomers present in volatile oils, especially within monoterpenes and sesquiterpenes, more attention should be paid for identification using mass spectra. In order to enhance the reliability of the identification by MS, both similarity and reverse match factor should be used. According to our experience and the literature data \[[@B18]--[@B20]\], 167 compounds with good match were tentatively identified including 50 monoterpenes, 36 sesquiterpenes, 31 esters and acids, 9 aldehydes and ketones, 6 alcohols, 3 ethers, 12 phenyl compounds, and 20 other components. Compounds have lower search probabilities than these counted as unknowns, and were disqualified for Kovats index comparison. [Table 1](#tab1){ref-type="table"} listed 167 components identified in Chenpi volatile oil. The volatile fraction is characterized by high percentages of monoterpenes, sesquiterpenes, and esters, including *β*-elemene, p-mentha-1(7),8(10)-dien-9-ol, and limonene. In this study, many components have also been tentatively identified, which were found in Chenpi volatile oil for the first time such as globulol and isoledene. There is high possibility that they will be literally useful for further pharmaceutical research of Chenpi volatile oil.

3.2. Group Separation of Chenpi Volatile Components {#sec3.2}
---------------------------------------------------

In GC × GC-HR-TOFMS analysis, the 167 identified volatile components in Chenpi volatile oil were mainly classified into two groups that can be seen in [Figure 3](#fig3){ref-type="fig"}. Based on GC × GC-HR-TOFMS, it can be found that the peaks in areas A and B are monoterpenes and sesquiterpenes, respectively. These monoterpenes and sesquiterpenes are mainly alkenes, alcohols, and ethers. It was also found that a lot of saturated and unsaturated fatty acid esters and phenyl compounds constitute the Chenpi volatile oil. This study demonstrates that GC × GC-HR-TOFMS is a powerful separation and identification tool that allows for the identification and group separation of a much larger number of complex volatile oil components.

3.3. Identification of Three Coelution Volatile Components in Chenpi Volatile Oil {#sec3.3}
---------------------------------------------------------------------------------

The high-resolution mass spectra in the TIC can be used for accurate identification of volatile compounds in Chenpi volatile oil, and these identified compounds will be significant to the further pharmaceutical research. For example, [Figure 4](#fig4){ref-type="fig"} compares the high resolution mass spectrum of the blob (peak) marked with 138 (49.14 min, 2.02 s), 104 (49.26 min, 1.58 s), and 77 (49.14 min, 1.45 s), head-to-tail with the mass spectrum of p-mentha-1(7),8(10)-dien-9-ol, dodecanal, and *β*-elemene TMS from the NIST/EPA/NIH library mass spectra. For p-mentha-1(7),8(10)-dien-9-ol, the forward match factor is 806; reverse match factor is 855; and probability is 20.12%. For dodecanal, the forward match factor is 763; reverse match factor is 773; and probability is 7.16%. For *β*-elemene, the forward match factor is 911; reverse match factor is 914; and probability is 17.11%. The above three volatile components cannot be clearly separated or identified by traditional one-dimensional gas chromatography or GC-MS method, because they are coelution volatile components, which have very similar chemical properties including volatility and polarity. In this study, the three coelution volatile components in Chenpi volatile oil were well separated and identified by GC × GC-HR-TOFMS, which have not been reported in other studies ([Figure 4](#fig4){ref-type="fig"}).

This study showed that GC × GC-HR-TOFMS represents a powerful separation and analysis tool for the analysis of complex volatile oils of herbal medicines. GC × GC-HR-TOFMS can give the information about the formula and structures, can provide the opportunity for differentiating different volatile oils, can give the subtle differences of the oils from different areas, and can find new compounds that have the possible pharmaceutical effect on some diseases.

4. Conclusions {#sec4}
==============

In this study, GC × GC-HR-TOFMS not only tentatively identified 167 volatile components in Chenpi volatile oil, but also provided several kinds of identification information that make the result more reliable. Among 167 components, there are 50 monoterpenes, 36 sesquiterpenes, 31 esters and acids, 9 aldehydes and ketones, 6 alcohols, 3 ethers, 12 phenyl compounds, and 20 other components. Monoterpenes and sesquiterpenes are the main components of Chenpi volatile oil. This study demonstrates a dependable method for the qualitative analysis of volatiles, which can achieve an accurate and comprehensive chromatographic profile with a low contamination risk and cost, as well as shortened sample preparation time. GC × GC-HR-TOFMS will play an important role in the analysis of volatile oils of herbal medicines in the future.
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![Flow chart of the chemical composition study of Chenpi volatile oil by GC × GC-HR-TOFMS.](ECAM2013-237541.001){#fig1}

![GC × GC-HR-TOFMS chromatogram (a) and three-dimensional chromatogram (b) of Chenpi volatile oil.](ECAM2013-237541.002){#fig2}

![The GC × GC contour plot of Chenpi volatile oil group separation result. Regions marked by squares (A) and (B) were identified mainly as monoterpenes and sesquiterpenes, respectively.](ECAM2013-237541.003){#fig3}

![Details of three coelution volatile components (peak 77, 104, 138) in GC × GC chromatogram. The spectra of *β*-elemene (peak 77), dodecanal (peak 104), and p-mentha-1(7),8(10)-dien-9-ol (peak 138) in sample and in NIST library, respectively.](ECAM2013-237541.004){#fig4}

###### 

167 main volatile components identified in the Chenpi volatile oil.

  No.       Compound name                                                                                       Peak I/min   Peak II/s   Volume     Library formula          Library probability   Library CAS no.
  --------- --------------------------------------------------------------------------------------------------- ------------ ----------- ---------- ------------------------ --------------------- -----------------
  \(1\)     Nonanal                                                                                             28.62        1.6         2367.153   C~9~H~18~O               50.1                  124-19-6
  \(2\)     Pyrrolizidine-3-one-5-ol, ethyl ether                                                               53.49        2.74        53.1709    C~9~H~15~NO~2~           17.7                  0-00-0
  \(3\)     2-Methoxy-4-vinylphenol                                                                             42.38        2.73        2959.926   C~9~H~10~O~2~            59.39                 7786-61-0
  \(4\)     Styrene                                                                                             14.14        1.65        731.272    C~8~H~8~                 36.4                  100-42-5
  \(5\)     Octanal                                                                                             21.38        1.58        2235.185   C~8~H~16~O               62.19                 124-13-0
  \(6\)     Ethylbenzene                                                                                        12.57        1.39        484.4996   C~8~H~10~                64.86                 100-41-4
  \(7\)     Pterin-6-carboxylic acid                                                                            11.24        0.82        50.3913    C~7~H~5~N~5~O~3~         40.94                 948-60-7
  \(8\)     Hexadecane, 1,1-bis(dodecyloxy)-                                                                    77.27        1.2         102.3988   C~40~H~82~O~2~           9.24                  56554-64-4
  \(9\)     1-Heptatriacotanol                                                                                  75.09        2.76        169.2274   C~37~H~76~O              54.56                 105794-58-9
  \(10\)    Cholestan-3-ol, 2-methylene-, (3*β*,5*α*)-                                                          64.35        2.11        268.4351   C~28~H~48~O              13.09                 22599-96-8
  \(11\)    \[5,9-Dimethyl-1-(3-phenyl-oxiran-2-yl)-deca-4,8-dienylidene\]-(2-phenyl-aziridin-1-yl)-amine       66.4         2.23        151.311    C~28~H~34~N~2~O          44.04                 0-00-0
  \(12\)    1,1′-(4-Methyl-1,3-phenylene)bis\[3-(5-benzyl-1,3,4-thiadiazol-2-yl)urea\]                          23.55        2.15        106.0574   C~27~H~24~N~8~O~2~S~2~   24.95                 0-00-0
  \(13\)    Morphinan-4,5-epoxy-3,6-di-ol, 6-\[7-nitrobenzofurazan-4-yl\]amino-                                 46.49        0.79        105.5334   C~26~H~27~N~5~O~6~       9.48                  0-00-0
  \(14\)    Benzene, 1,1′-\[3-(3-cyclopentylpropyl)-1,5-pentanediyl\]bis-                                       7.74         1.18        149.2865   C~25~H~34~               15.18                 55191-62-3
  \(15\)    2-(2-Azepan-1-yl-2-oxoethyl)-1-hydroxy-1-phenyl-octahydro-pyrido\[1,2-a\]azepin-4-one               76.42        2.77        142.1083   C~24~H~34~N~2~O~3~       52.15                 0-00-0
  \(16\)    6,9,12,15-Docosatetraenoic acid, methyl ester                                                       59.4         1.77        55.943     C~23~H~38~O~2~           19.28                 17364-34-0
  \(17\)    2-\[4-Methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-trienyl\]cyclohex-1-en-1-carboxaldehyde   53.49        2.15        64.4497    C~23~H~32~O              25.57                 0-00-0
  \(18\)    Naphthalen-2-yl-acetic acid, 6-hydroxy-6-methyl-cyclodecyl ester                                    41.54        2.63        65.5915    C~23~H~30~O~3~           27.3                  0-00-0
  \(19\)    Z-5-Methyl-6-heneicosen-11-one                                                                      80.89        1.11        115.1736   C~22~H~42~O              8.27                  0-00-0
  \(20\)    2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro-                                                          61.45        1.91        133.6559   C~22~H~40~O~2~           14.4                  56599-50-9
  \(21\)    Doconexent                                                                                          17.88        1.63        127.9331   C~22~H~32~O~2~           40.98                 6217-54-5
  \(22\)    9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester, (Z,Z,Z)-                                  31.16        2.22        105.1463   C~21~H~36~O~4~           19.78                 18465-99-1
  \(23\)    8,11,14-Eicosatrienoic acid, methyl ester, (Z,Z,Z)-                                                 42.75        2.02        216.8234   C~21~H~36~O~2~           8.42                  21061-10-9
  \(24\)    5,8,11-Eicosatrienoic acid, methyl ester                                                            57.59        2.03        96.1455    C~21~H~30~O~2~           43.95                 0-00-0
  \(25\)    cis-5,8,11,14,17-Eicosapentaenoic acid                                                              24.52        4.25        53.7632    C~20~H~30~O~2~           13.99                 10417-94-4
  \(26\)    5,8,11,14-Eicosatetraynoic acid                                                                     58.8         3.17        144.9613   C~20~H~24~O~2~           29.78                 1191-85-1
  \(27\)    1,16-Cyclocorynan-17-oic acid, 19,20-didehydro-, methyl ester, (16S,19E)-                           12.21        0.64        88.5548    C~20~H~22~N~2~O~2~       53.45                 6393-66-4
  \(28\)    Octadecane, 6-methyl-                                                                               82.09        1.25        184.9235   C~19~H~40~               18.41                 10544-96-4
  \(29\)    2-Methyl-E,E-3,13-octadecadien-1-ol                                                                 64.83        2.01        124.0941   C~19~H~36~O              9.74                  0-00-0
  \(30\)    Z,Z,Z-4,6,9-Nonadecatriene                                                                          26.81        1.7         109.996    C~19~H~34~               21.05                 0-00-0
  \(31\)    6,9,12-Octadecatrienoic acid, methyl ester                                                          55.78        2.92        63.7153    C~19~H~32~O~2~           28.52                 2676-41-7
  \(32\)    Z,Z,Z-1,4,6,9-Nonadecatetraene                                                                      21.5         1.8         65.4446    C~19~H~32~               14.64                 0-00-0
  \(33\)    12,15-Octadecadienoic acid, methyl ester                                                            49.14        2.35        158.5734   C~19~H~30~O~2~           19.33                 57156-95-3
  \(34\)    10,13-Octadecadienoic acid, methyl ester                                                            50.47        2.47        161.0184   C~19~H~30~O~2~           15.45                 18202-24-9
  \(35\)    2,5-Octadecadienoic acid, methyl ester                                                              59.52        1.99        254.7258   C~19~H~30~O~2~           10.15                 57156-91-9
  \(36\)    2,2,4,4-Tetramethyl-6-(1-oxo-3-phenylprop-2-enyl)-cyclohexane-1,3,5-trione                          70.27        0.49        83.2401    C~19~H~20~O~4~           21.98                 0-00-0
  \(37\)    Gentamicina                                                                                         63.63        3.21        62.6103    C~18~H~36~N~4~O~10~      27.05                 13291-74-2
  \(38\)    Z-10-Methyl-11-tetradecen-1-ol propionate                                                           40.33        2           70.3719    C~18~H~34~O~2~           10.53                 0-00-0
  \(39\)    10-Heptadecen-8-ynoic acid, methyl ester, (E)-                                                      34.18        2.06        63.2456    C~18~H~30~O~2~           14.6                  16714-85-5
  \(40\)    *α*-L-Fucopyranose 1,2:3,4-bis(benzeneboronate)                                                     67.13        2.28        180.5156   C~18~H~18~B~2~O~5~       25.89                 102281-26-5
  \(41\)    3-(O-Anisidinomethyl)-5-(3-fluorobenzylidene)-2,4-thiazolidinedione                                 34.66        2.46        82.9072    C~18~H~15~FN~2~O~3~S     9.43                  302954-96-7
  \(42\)    1-Hexadecanol, 2-methyl-                                                                            44.19        1.03        65.1528    C~17~H~36~O              11.82                 2490-48-4
  \(43\)    10-Methyl-E-11-tridecen-1-ol propionate                                                             33.33        1.56        164.2353   C~17~H~32~O~2~           6.69                  0-00-0
  \(44\)    13-Heptadecyn-1-ol                                                                                  40.09        2.25        78.5129    C~17~H~32~O              12.04                 56554-77-9
  \(45\)    4,7,10-Hexadecatrienoic acid, methyl ester                                                          32.97        2.05        83.5894    C~17~H~28~O~2~           7.98                  17364-31-7
  \(46\)    Methyl 5,7-hexadecadienoate                                                                         53.61        1.7         58.765     C~17~H~26~O~2~           14.34                 0-00-0
  \(47\)    3-(5-Benzyloxy-3-methylpent-3-enyl)-2,2-dimethyloxirane                                             35.02        2.61        96.359     C~17~H~24~O~2~           8.95                  0-00-0
  \(48\)    Falcarinol                                                                                          37.07        1.57        55.0178    C~17~H~24~O              35.51                 21852-80-2
  \(49\)    tert-Hexadecanethiol                                                                                70.27        1.03        151.5898   C~16~H~34~S              13.87                 25360-09-2
  \(50\)    n-Hexadecanoic acid                                                                                 79.08        1.74        705.7247   C~16~H~32~O~2~           43.05                 10-3-1957
  \(51\)    Cyclopentaneundecanoic acid                                                                         46.49        1.62        94.519     C~16~H~30~O~2~           13.97                 6053-49-2
  \(52\)    9-Hexadecenoic acid                                                                                 65.56        1.91        89.144     C~16~H~30~O~2~           13.29                 2091-29-4
  \(53\)    Formic acid, 3,7,11-trimethyl-1,6,10-dodecatrien-3-yl ester                                         51.92        1.71        99.1647    C~16~H~26~O~2~           23.72                 0-00-0
  \(54\)    1,3-Dioxolane, 2-heptyl-4-phenyl-                                                                   7.74         0.67        137.1547   C~16~H~24~O~2~           20.64                 55668-40-1
  \(55\)    Peyonine                                                                                            24.64        0.58        54.9972    C~16~H~19~NO~5~          27.28                 19717-25-0
  \(56\)    12,14,14-Trimethyl-3,6,9-trioxapentadecan-1-ol                                                      66.52        1.18        58.5099    C~15~H~32~O~4~           16.94                 55489-54-8
  \(57\)    Isocalamendiol                                                                                      73.65        2.76        52.3348    C~15~H~26~O~2~           24.27                 0-00-0
  \(58\)    Geranyl isovalerate                                                                                 53.37        1.03        77.0183    C~15~H~26~O~2~           11.72                 109-20-6
  \(59\)    Cubeduel                                                                                            63.26        1.88        203.2965   C~15~H~26~O              24.8                  0-00-0
  \(60\)    *α*-Cadinol                                                                                         63.63        2.07        649.3081   C~15~H~26~O              24.36                 481-34-5
  \(61\)    Cubenol                                                                                             62.42        1.9         408.4446   C~15~H~26~O              16.17                 21284-22-0
  \(62\)    .tau.-Cadinol                                                                                       63.02        2           707.983    C~15~H~26~O              11.7                  11-1-5937
  \(63\)    *α*-Acorenol                                                                                        63.63        2.17        1949.884   C~15~H~26~O              9.72                  0-00-0
  \(64\)    Globulol                                                                                            60.13        1.88        278.3377   C~15~H~26~O              6.4                   51371-47-2
  \(65\)    7-Epi-cis-sesquisabinene hydrate                                                                    54.57        1.3         81.2625    C~15~H~26~O              6.4                   0-00-0
  \(66\)    Limonen-6-ol, pivalate                                                                              44.56        1.85        78.8648    C~15~H~24~O~2~           24.04                 0-00-0
  \(67\)    Aromadendrene oxide-(2)                                                                             62.78        2.09        96.7312    C~15~H~24~O              15.84                 0-00-0
  \(68\)    Caryophyllene oxide                                                                                 59.88        2           161.5517   C~15~H~24~O              13.15                 1139-30-6
  \(69\)    Spiro\[4.5\]dec-6-en-8-one, 1,7-dimethyl-4-(1-methylethyl)-                                         38.16        2.27        73.2272    C~15~H~24~O              7.02                  39510-36-6
  \(70\)    Humulene                                                                                            53           1.61        5204.711   C~15~H~24~               44.49                 6753-98-6
  \(71\)    (Z,E)-*α*-farnesene                                                                                 55.78        1.52        31067.6    C~15~H~24~               42.94                 26560-14-5
  \(72\)    *α*-Copaene                                                                                         48.42        1.4         7508.707   C~15~H~24~               42.37                 0-00-0
  \(73\)    *δ*-Elemene                                                                                         45.88        1.33        5692.139   C~15~H~24~               38.01                 20307-84-0
  \(74\)    Naphthalene, 1,2,3,5,6,8a-hexahydro- 4,7-dimethyl-1-(1-methylethyl)-, (1S-cis)-                     56.75        1.68        12956.64   C~15~H~24~               31                    483-76-1
  \(75\)    1,3,6,10-Dodecatetraene, 3,7,11-trimethyl-, (Z,E)-                                                  54.94        1.51        196.9983   C~15~H~24~               29.01                 26560-14-5
  \(76\)    Caryophyllene                                                                                       50.95        1.54        3006.936   C~15~H~24~               17.9                  87-44-5
  \(77\)    *β*-Elemene                                                                                         49.14        1.45        20347.87   C~15~H~24~               17.11                 515-13-9
  \(78\)    *α*-Guaiene                                                                                         52.16        1.47        556.5085   C~15~H~24~               16.63                 12-1-3691
  \(79\)    Cyclohexane, 1-ethenyl-1-methyl-2,4-bis (1-methylethenyl)-                                          52.76        1.23        160.6527   C~15~H~24~               16.42                 110823-68-2
  \(80\)    1,6-Cyclodecadiene, 1-Methyl-5-methylene-8-(1-methylethyl)-, \[S-(E,E)\]-                           54.45        1.65        14112      C~15~H~24~               15.25                 23986-74-5
  \(81\)    *γ*-Elemene                                                                                         51.68        1.51        742.7373   C~15~H~24~               15.14                 29873-99-2
  \(82\)    Naphthalene, 1,2,3,4,4a,7- hexahydro-1,6-dimethyl-4-(1-methylethyl)-                                57.35        1.71        200.7951   C~15~H~24~               14.55                 16728-99-7
  \(83\)    Cyclohexane, 1-ethenyl-1-methyl- 2,4-bis(1-methylethenyl)-, \[1S-(1*α*,2*β*,4*β*)\]-                48.66        1.47        549.6758   C~15~H~24~               10.66                 515-13-9
  \(84\)    *β*-Copaene                                                                                         54.45        1.55        561.4817   C~15~H~24~               10.53                 0-00-0
  \(85\)    *γ*-Elemene                                                                                         58.8         1.82        1698.139   C~15~H~24~               8.31                  29873-99-2
  \(86\)    *β*-Guaiene                                                                                         57.59        1.75        60.1417    C~15~H~24~               7.16                  88-84-6
  \(87\)    Guaia-1(10),11-diene                                                                                54.82        1.67        1093.799   C~15~H~24~               6.6                   0-00-0
  \(88\)    Isoledene                                                                                           54.21        1.58        405.0377   C~15~H~24~               6.27                  0-00-0
  \(89\)    4,5-Di-epi-aristolochene                                                                            47.81        1.43        90.0937    C~15~H~24~               4.2                   0-00-0
  \(90\)    trans-calamenene                                                                                    56.51        1.85        84.299     C~15~H~22~               38.35                 0-00-0
  \(91\)    *β*-Vatirenene                                                                                      73.65        2.34        437.4147   C~15~H~22~               25.71                 0-00-0
  \(92\)    4,4-Dimethyl-3-(3-methylbut-3-enylidene)-2-methylenebicyclo\[4.1.0\]heptane                         72.68        2.32        284.3733   C~15~H~22~               11.28                 79718-83-5
  \(93\)    7-Hydroxy-6,9a-dimethyl-3-methylene-decahydro-azuleno\[4,5-b\]furan-2,9-dione                       75.21        3.61        61.6952    C~15~H~20~O~4~           11.61                 0-00-0
  \(94\)    Propanoic acid, 3-(2,3,6-trimethyl- 1,4-dioxaspiro\[4.4\]non-7-yl)-, methyl ester                   33.93        2.7         84.8793    C~14~H~24~O~4~           19.92                 0-00-0
  \(95\)    2,5-Furandione, 3-(2-decenyl)dihydro-                                                               40.33        2.76        154.1135   C~14~H~22~O~3~           11.38                 62568-81-4
  \(96\)    trans-(2-Decenyl)succinic anhydride                                                                 72.08        1.6         67.8793    C~14~H~22~O~3~           10.39                 81949-64-6
  \(97\)    1,4-Benzenediol, 2,6-bis(1,1-dimethylethyl)-                                                        77.51        0.5         70.9573    C~14~H~22~O~2~           7.13                  2444-28-2
  \(98\)    Tetraacetyl-d-xylonic nitrile                                                                       58.32        1.62        100.275    C~14~H~17~NO~9~          18.48                 0-00-0
  \(99\)    *α*-Ionol                                                                                           30.19        2.18        277.9312   C~13~H~22~O              15.16                 25312-34-9
  \(100\)   1-(2-Acetoxyethyl)-3,6-diazahomoadamantan-9-one oxime                                               73.28        0.5         55.2116    C~13~H~21~N~3~O~3~       8.78                  0-00-0
  \(101\)   1b,5,5,6a-Tetramethyl-octahydro-1-oxa-cyclopropa\[a\]inden-6-one                                    33.21        1.89        138.6104   C~13~H~20~O~2~           6.45                  0-00-0
  \(102\)   Pyrimidin-2-one, 4-\[N-methylureido\]-1-\[4-methylaminocarbonyloxymethyl                            68.94        0.38        54.3663    C~13~H~19~N~5~O~5~       23.12                 0-00-0
  \(103\)   2H-Indeno\[1,2-b\]furan-2-one, 3,3a,4,5,6,7,8,8b-octahydro-8,8-dimethyl                             55.3         1.93        203.2335   C~13~H~18~O~2~           28.93                 0-00-0
  \(104\)   Dodecanal                                                                                           49.26        1.58        1282.104   C~12~H~24~O              6.6                   112-54-9
  \(105\)   2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (Z)-                                                     46.37        1.74        3059.872   C~12~H~20~O~2~           37.64                 141-12-8
  \(106\)   Geranyl acetate                                                                                     47.45        1.79        3772.587   C~12~H~20~O~2~           28.7                  105-87-3
  \(107\)   (R)-Lavandulyl acetate                                                                              46.37        2.25        81.7472    C~12~H~20~O~2~           14.19                 0-00-0
  \(108\)   Geranyl vinyl ether                                                                                 36.83        1.77        76.0262    C~12~H~20~O              14.31                 0-00-0
  \(109\)   3′-Hydroxyquinalbarbitone                                                                           39.61        1.5         51.4505    C~12~H~18~N~2~O~4~       10.72                 839-21-4
  \(110\)   Non-1-yn-5-en-9-aldehyde, 4-carbethoxy-                                                             44.31        2.11        115.1319   C~12~H~16~O~3~           17.87                 0-00-0
  \(111\)   Undecanal                                                                                           42.75        1.59        704.5031   C~11~H~22~O              33.86                 112-44-7
  \(112\)   Cyclohexane, 2-ethenyl-1,1-dimethyl-3-methylene-                                                    30.31        1.34        135.2002   C~11~H~18~               23.83                 95452-08-7
  \(113\)   Cyclohexene, 2-ethenyl-1,3,3-trimethyl-                                                             42.02        2.22        591.2578   C~11~H~18~               14.36                 5293-90-3
  \(114\)   Acetic acid, octyl ester                                                                            36.47        1.49        323.6557   C~10~H~20~O~2~           17.84                 112-14-1
  \(115\)   Decanal                                                                                             35.74        1.61        7031.098   C~10~H~20~O              61.62                 112-31-2
  \(116\)   Cephrol                                                                                             37.55        1.66        328.2375   C~10~H~20~O              12.34                 40607-48-5
  \(117\)   Linalol                                                                                             28.74        1.52        3645.373   C~10~H~18~O              81.59                 78-70-6
  \(118\)   *α*-Terpineol                                                                                       34.9         1.89        7440.985   C~10~H~18~O              67.75                 98-55-5
  \(119\)   Terpinen-4-ol                                                                                       34.18        1.79        3293.372   C~10~H~18~O              50.03                 562-74-3
  \(120\)   Citronellal                                                                                         32.12        1.69        615.3934   C~10~H~18~O              42.59                 106-23-0
  \(121\)   2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, cis-                                                30.31        1.67        159.2231   C~10~H~18~O              39.11                 29803-82-5
  \(122\)   Cyclohexanol, 1-methyl-4-(1-methylethenyl)-, cis-                                                   31.64        1.8         726.8632   C~10~H~18~O              10.59                 7299-41-4
  \(123\)   2-Cyclohexen-1-ol, 2-methyl-5-(1-methylethyl)-, (1S-cis)-                                           36.11        1.85        101.2405   C~10~H~18~O              10.53                 536-30-1
  \(124\)   exo-2,7,7-trimethylbicyclo\[2.2.1\]heptan-2-ol                                                      32.97        1.89        169.9902   C~10~H~18~O              8.15                  0-00-0
  \(125\)   5-Hepten-1-ol, 2-ethenyl-6-methyl-                                                                  45.76        1.68        397.1537   C~10~H~18~O              7.75                  18479-48-6
  \(126\)   Bicyclo\[4.1.0\]heptane, 3,7,7-trimethyl-, \[1S-(1*α*,3*β*,6*α*)\]-                                 45.76        1.58        368.8305   C~10~H~18~               9.72                  2778-68-9
  \(127\)   Desulphosinigrin                                                                                    66.64        1.06        73.3518    C~10~H~17~NO~6~S         8.92                  5115-81-1
  \(128\)   R-Limonene                                                                                          39.37        2.73        97.0311    C~10~H~16~O~3~           40.37                 0-00-0
  \(129\)   Limonene oxide, trans-                                                                              31.28        1.78        570.8168   C~10~H~16~O              54.24                 4959-35-7
  \(130\)   Limonene oxide, cis-                                                                                30.92        1.78        1068.476   C~10~H~16~O              40.43                 13837-75-7
  \(131\)   trans-p-Mentha-2,8-dienol                                                                           30.07        1.78        448.7691   C~10~H~16~O              34.35                 0-00-0
  \(132\)   3-Cyclohexene-1-acetaldehyde, *α*,4-dimethyl-                                                       36.35        2.09        181.7561   C~10~H~16~O              31.38                 29548-14-9
  \(133\)   cis-p-Mentha-1(7),8-dien-2-ol                                                                       37.43        2.05        398.5489   C~10~H~16~O              26.42                 0-00-0
  \(134\)   (Z)-Carveol                                                                                         35.5         1.97        452.2402   C~10~H~16~O              25.48                 1197-06-4
  \(135\)   trans-Carveol                                                                                       36.71        2           1591.657   C~10~H~16~O              22.66                 1197-07-5
  \(136\)   cis-p-Mentha-1(7),8-dien-2-ol                                                                       33.93        1.91        336.4337   C~10~H~16~O              21.5                  0-00-0
  \(137\)   1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-                                                      35.62        1.89        195.9113   C~10~H~16~O              20.76                 536-59-4
  \(138\)   p-Mentha-1(7),8(10)-dien-9-ol                                                                       49.14        2.02        1162.984   C~10~H~16~O              20.12                 29548-13-8
  \(139\)   cis-p-Mentha-2,8-dien-1-ol                                                                          43.47        1.91        99.0278    C~10~H~16~O              7.83                  3886-78-0
  \(140\)   2,6-Dimethyl-3,5,7-octatriene-2-ol, E,E-                                                            31.88        1.98        187.0291   C~10~H~16~O              7.6                   0-00-0
  \(141\)   (S)-(-)-(4-Isopropenyl-1-cyclohexenyl)methanol                                                      35.38        1.89        172.7702   C~10~H~16~O              5.86                  18457-55-1
  \(142\)   Bicyclo\[3.1.0\]hex-2-ene, 4-methyl-1-(1-methylethyl)-                                              17.4         1.11        7918.412   C~10~H~16~               65.04                 28634-89-1
  \(143\)   *β*-Pinene                                                                                          20.66        1.31        19964.34   C~10~H~16~               40.8                  127-91-3
  \(144\)   *β*-Ocimene                                                                                         25.48        1.34        4519.345   C~10~H~16~               37.56                 13877-91-3
  \(145\)   *α*-Phellandrene                                                                                    22.47        1.32        2085.008   C~10~H~16~               33.42                 99-83-2
  \(146\)   *β*-Myrcene                                                                                         21.5         1.27        69260.99   C~10~H~16~               31.3                  123-35-3
  \(147\)   *α*-Pinene                                                                                          17.88        1.16        48376.96   C~10~H~16~               23.82                 80-56-8
  \(148\)   Camphene                                                                                            18.85        1.22        406.4708   C~10~H~16~               19.93                 79-92-5
  \(149\)   *β*-Phellandrene                                                                                    20.29        1.27        4173.575   C~10~H~16~               19.68                 555-10-2
  \(150\)   D-Limonene                                                                                          24.52        1.69        1784450    C~10~H~16~               19.59                 5989-27-5
  \(151\)   *α*-Terpinene                                                                                       23.43        1.33        4905.547   C~10~H~16~               17.58                 99-86-5
  \(152\)   Isoterpinene                                                                                        28.38        1.46        14607.02   C~10~H~16~               16.01                 586-62-9
  \(153\)   *γ*-Terpinene                                                                                       26.33        1.5         189808.1   C~10~H~16~               15.28                 99-85-4
  \(154\)   1,5,5-Trimethyl-6-methylene-cyclohexene                                                             26.33        1.86        305.9981   C~10~H~16~               9.81                  514-95-4
  \(155\)   Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (S)-                                                    24.52        3.31        51.7426    C~10~H~16~               9.58                  5989-54-8
  \(156\)   *γ*-Pyronene                                                                                        23.07        1.27        60.3834    C~10~H~16~               5.33                  514-95-4
  \(157\)   5-Isopropenyl-2-methylcyclopent-1-enecarboxaldehyde                                                 36.11        2.3         711.2013   C~10~H~14~O              34.31                 0-00-0
  \(158\)   (-)-Carvone                                                                                         37.8         2.35        909.8454   C~10~H~14~O              32.76                 6485-40-1
  \(159\)   1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-                                                39.85        2.43        1404.104   C~10~H~14~O              31.76                 2111-75-3
  \(160\)   3,5-Heptadienal, 2-ethylidene-6-methyl-                                                             36.95        2.28        238.0085   C~10~H~14~O              28.28                 99172-18-6
  \(161\)   Benzenemethanol, *α*,*α*,4-trimethyl-                                                               34.05        2.28        288.3869   C~10~H~14~O              16.59                 1197-01-9
  \(162\)   Cyclohexanone, 2-(2-butynyl)-                                                                       42.38        3.18        59.1028    C~10~H~14~O              15.02                 54166-48-2
  \(163\)   D-Verbenone                                                                                         41.42        2.16        475.2141   C~10~H~14~O              11.63                 18309-32-5
  \(164\)   3,5-Heptadienal, 2-ethylidene-6-methyl-                                                             36.11        2.5         184.88     C~10~H~14~O              8.97                  99172-18-6
  \(165\)   o-Cymene                                                                                            23.55        1.55        35991.09   C~10~H~14~               47.51                 527-84-4
  \(166\)   2,6-Dimethyl-1,3,5,7-octatetraene, E,E-                                                             31.64        1.71        164.8089   C~10~H~14~               20.19                 460-01-5
  \(167\)   Benzene, 1-methyl-4-(1-methylethenyl)-                                                              27.9         1.8         271.6784   C~10~H~12~               20.42                 1195-32-0

[^1]: Academic Editor: Carlo Ventura
